Viewing nowYuyu Creed Tablet 100mg (Ticlopidine Hydrochloride)
Ticlopidine Hydrochloride 100mg
Prescription medication
Yuyu Pharmaceutical Co., Ltd.

MFDS item code 198300092 · Notified 1983.10.20 · Insurance code 644500940
Prevention and treatment of thrombosis and embolism, improvement of impaired blood flow, and improvement of ischemic symptoms
This medication helps treat thrombosis or embolism that may occur during vascular surgery or extracorporeal circulation, improving blood flow disorders. It is also used to alleviate ischemic symptoms such as ulcers, pain, and coldness due to chronic arterial obstruction. Additionally, it treats thrombosis and embolism related to ischemic cerebrovascular disorders and is effective in improving blood flow disorders from vasospasm following subarachnoid hemorrhage surgery. It prevents and treats thrombosis and embolism in coronary artery disease such as angina pectoris and myocardial infarction, contributing to the relief of ischemic symptoms. Furthermore, it is used to prevent subacute thrombosis during stent insertion in coronary arteries, aiding in the treatment and prevention of various vascular-related diseases.
1. Treatment of thrombi and emboli associated with vascular surgery and extracorporeal circulation, and improvement of impaired blood flow: The usual adult dose is 200~300mg of ticlopidine hydrochloride per day, administered orally in 2~3 divided doses after meals. Reduce the dose appropriately according to the patient's condition. 2. Improvement of ischemic symptoms such as ulcers, pain, and coldness associated with chronic arterial occlusive disease: The usual adult dose of this drug is 300~600mg per day, administered orally in 2~3 divided doses after meals. Reduce the dose appropriately according to the patient's condition. 3. Treatment of thrombi and emboli associated with ischemic cerebrovascular disorders: The usual adult dose of this drug is 500mg per day, administered orally in 2 divided doses after meals. Reduce the dose appropriately according to the patient's condition. 4. Improvement of impaired blood flow due to cerebral vasospasm after surgery for subarachnoid hemorrhage: The usual adult dose of this drug is 300mg per day, administered orally in 3 divided doses after meals. Reduce the dose appropriately according to the patient's condition. 5. Prevention and treatment of thrombi and emboli associated with coronary artery disease (angina, myocardial infarction), and treatment of ischemic symptoms: The usual adult dose of this drug is 500mg per day, administered orally in 2 divided doses after meals. Adjust the dose appropriately according to age and symptoms. 6. Prevention of subacute thrombosis after intracoronary stent placement: Start administration on the day before stent placement or on the day of placement. Administer 500mg of this drug per day orally in 2 divided doses, in combination with aspirin (100~325mg per day), after meals for 4~6 weeks.
This medication may cause severe side effects such as thrombotic thrombocytopenic purpura, agranulocytosis, and severe liver impairment, primarily within 2 months of starting treatment, requiring special caution. Blood tests and liver function tests should be conducted every two weeks for the first three months after starting treatment, and if any abnormal symptoms occur, the medication should be stopped immediately, and medical attention should be sought. This medication poses a high risk of hematological adverse reactions and bleeding, so it should be used with caution when taken with other blood-related medications such as anticoagulants or aspirin. It should not be used in patients with bleeding risks, severe liver impairment, leukopenia or thrombocytopenia, or those allergic to this medication or its ingredients. Special caution is required for patients during menstruation, those taking anticoagulants, patients with a history of liver disease, those scheduled for surgery, patients with hypertension, and elderly patients. This medication can produce various side effects, including decreased blood cell count, bleeding, liver function abnormalities, gastrointestinal disorders, and allergic reactions, so immediate consultation with medical personnel is necessary if symptoms occur. Regular blood tests and liver function tests should be carried out to check for abnormalities during treatment, especially during the first three months, meticulous observation is essential. Since this medication is metabolized in the liver, it should be used cautiously in patients with impaired liver function, and those with compromised kidney function should also be monitored closely. Due to numerous drug interactions, the risk of bleeding may increase when taken with non-steroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants, so it is crucial to consult a doctor. Pregnant or breastfeeding women should avoid this medication, and its safety and effectiveness in children have not been established, thus its use is not recommended. In elderly patients, metabolic and hematopoietic functions may decline, increasing the risk of side effects, so initiation at a lower dose is advised, and careful monitoring of their condition is necessary. In case of overdose, the risk of bleeding may increase; therefore, it is essential to adhere strictly to dosage recommendations and to notify medical personnel immediately if any unusual symptoms occur.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or humidity, so it should be stored in a tightly sealed container. It is also preferable to store it at room temperature, avoiding extremes of heat or cold.
White round sugar-coated tablets
30 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.